Gabapentin to Pregabalin Conversion
When switching from gabapentin 800 mg three times daily (2400 mg/day total) to pregabalin, start with pregabalin 400 mg/day (either 200 mg twice daily or approximately 133 mg three times daily), which represents a 1:6 conversion ratio.
Conversion Rationale
The 1:6 conversion ratio (gabapentin:pregabalin) is supported by both pharmacokinetic modeling 1 and clinical evidence 2. This means:
- Gabapentin 2400 mg/day → Pregabalin 400 mg/day
This conversion accounts for pregabalin's superior bioavailability (≥90% regardless of dose) compared to gabapentin's saturable absorption (bioavailability drops from 60% at 900 mg/day to 33% at 3600 mg/day) 3.
Transition Methods
You have two evidence-based options 1:
Option 1: Immediate Switch (Preferred for Simplicity)
- Stop gabapentin completely
- Start pregabalin 400 mg/day at the next scheduled dose
- Pharmacokinetic simulations show seamless transition with pregabalin-equivalent concentrations achieved within 1 day 1
Option 2: Gradual Transition (If Concerned About Withdrawal)
- Days 1-4: Give 50% of gabapentin dose (400 mg TID = 1200 mg/day) + 50% of target pregabalin dose (200 mg/day)
- Day 5 onward: Stop gabapentin, continue full pregabalin 400 mg/day
- Pregabalin-equivalent concentrations stabilize within 1 day of stopping gabapentin 1
Dosing Schedule Options
Pregabalin 400 mg/day can be administered as:
- 200 mg twice daily (simpler, better compliance)
- 133 mg three times daily (maintains current TID schedule)
The FDA label supports both BID and TID dosing 4, though BID is more practical.
Titration After Conversion
If pain control is inadequate after 1-2 weeks on pregabalin 400 mg/day 5:
- Increase to 600 mg/day (300 mg BID or 200 mg TID) - the maximum FDA-approved dose 4
- Titrate by 150 mg/day increments every 3-7 days as tolerated 5
- Note: Doses above 300 mg/day show inconsistent additional benefit and higher adverse event rates 5
Critical Considerations
Renal Function
Both medications require dose adjustment in renal impairment 5, 4, 6. Check creatinine clearance before conversion and adjust accordingly using FDA dosing tables.
Side Effect Profile Differences
- Pregabalin causes more peripheral edema than gabapentin 2
- Gabapentin may cause more anxiety, insomnia, and fatigue 7
- Both cause dose-dependent dizziness and sedation 5
- Monitor closely during the first 2 weeks post-conversion
Efficacy Expectations
Recent meta-analyses show pregabalin provides superior pain reduction compared to gabapentin 8, with faster onset of action 2, 3. Your patient may experience:
- Improved pain control at the equivalent dose
- Faster time to effect (pregabalin peaks in 1 hour vs. 3-4 hours for gabapentin) 3
- More predictable dosing due to linear pharmacokinetics 5, 3
Common Pitfall to Avoid
Do not use a 1:1 conversion ratio - this would result in massive underdosing. The 1:6 ratio is pharmacologically validated 1, 2, 3.
Schedule V Consideration
Pregabalin is a Schedule V controlled substance in the United States 5, while gabapentin scheduling varies by state - ensure appropriate prescribing documentation.